Analyst Ratings for Onyx Pharmaceuticals (ONXX) [Buys]

Overall Rating: BUY Rating Trend: = Avg. $ Target: $85.06 (-10.7%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
2/8/2013	JMP Securities	New Coverage	Market Outperform (N/A)	100.00 (N/A)	76.11	95.23	25.12%	Details
12/19/2012	UBS	New Coverage	Buy (N/A)	97.00 (N/A)	80.83	95.23	17.82%	Details
12/7/2012	Dawson James	New Coverage	Market Outperform (N/A)	91.00 (N/A)	76.70	95.23	24.16%	Details
10/11/2012	Canaccord Genuity	New Coverage	Buy (N/A)	105.00 (N/A)	86.50	95.23	10.09%	Details
9/27/2012	Brean Capital » Updated 5/20/2013	New Coverage	Buy (N/A)	115.00 (105.00)	82.52	95.23	15.4%	Details
7/23/2012	Jefferies » Updated 3/19/2013	Upgrade	Buy (Hold)	104.00 (96.00)	76.38	95.23	24.68%	Details
7/20/2012	Barclays	Upgrade	Overweight (Equalweight)	85.00 (N/A)	68.40	95.23	39.23%	Details
7/20/2012	Leerink Swann	Upgrade	Outperform (Market Perform)	N/A (N/A)	68.40	95.23	39.23%	Details
6/21/2012	Cowen	Upgrade	Outperform (Neutral)	N/A (N/A)	61.38	95.23	55.15%	Details
6/21/2012	Baird » Updated 1/4/2013	Upgrade	Outperform (Neutral)	99.00 (99.00)	61.38	95.23	55.15%	Details
6/21/2012	Deutsche Bank » Updated 8/16/2012	New Coverage	Buy (N/A)	105.00 (N/A)	61.38	95.23	55.15%	Details
6/8/2012	BofA/Merrill Lynch	Upgrade	Buy (Neutral)	57.00 (47.00)	43.60	95.23	118.42%	Details
5/3/2012	Goldman Sachs » Updated 6/21/2012	Downgrade	Buy (N/A)	63.00 (52.00)	45.00	95.23	111.62%	Details
12/1/2011	Rodman & Renshaw » Updated 6/21/2012	New Coverage	Market Outperform (N/A)	73.00 (58.00)	44.10	95.23	115.94%	Details
10/13/2011	BMO Capital » Updated 6/21/2012	Upgrade	Outperform (N/A)	74.00 (55.00)	34.49	95.23	176.11%	Details

Like ONXX Ratings? Also take a look at LGND, GSK, YHOO, PURE